Menu Back toLS22: Ways to Reduce Hurdles for Clinical Trial Participation by Conducting Good Participatory Practice Workshop Part 1

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS22: Ways to Reduce Hurdles for Clinical Trial Participation by Conducting Good Participatory Practice Workshop Part 1

Session Chair(s)

Junko  Sato, PhD

Junko Sato, PhD

  • Director, Office of International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

Tatsuo  Iiyama, MD

Tatsuo Iiyama, MD

  • Director, Department of International Trial (DIT)
  • National Center for Global Health and Medicine, Japan
Takayuki  Imaeda, MPharm, MS

Takayuki Imaeda, MPharm, MS

  • Head of Regulatory Affairs
  • Pfizer R&D Japan, Japan

Contact us